Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now under review

Medical Xpress

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting.

The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of preclinical research, pivotal safety studies, regulatory engagement and clinical trial development. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now under review

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Outbreak of diarrhea-causing parasite grows to more than 1,000 cases

Pregnant women may avoid child protection out of fear and mistrust

Why some people are more bothered by low-frequency sounds

Medical Xpress의 다른 기사

AI can't replace mental health therapists. But here's where it might make a difference

Softening aging ovaries could help extend fertility as women get older

Learning to identify new objects reshapes parts of the brain, research finds